Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 20/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30990436 | 0.79 | RET (0.54) | RET | |
| SCHEMBL21179050 | 0.77 | RET (0.75) | RET | |
| SCHEMBL30381942 | 0.77 | RET (0.75) | RET | |
| SCHEMBL30990430 | 0.75 | RET (0.53) | RET | |
| SCHEMBL31639871 | 0.75 | RET (0.55) | RET | |
| SCHEMBL30990418 | 0.74 | RET (0.54) | RET | |
| SCHEMBL30990449 | 0.74 | RET (0.54) | RET | |
| SCHEMBL30990425 | 0.74 | EGFR (0.66) | RET | |
| SCHEMBL30990450 | 0.73 | RET (0.51) | RET | |
| SCHEMBL30990471 | 0.73 | RET (0.53) | RET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665720-A2 | ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE | Bristol-Myers Squibb Company (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024173832-A2 | ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-08-22 | — | — | WO | disclosed |